Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

45.85
+0.70001.55%
Pre-market: 45.58-0.2700-0.59%07:32 EDT
Volume:1.86M
Turnover:85.38M
Market Cap:109.86B
PE:24.59
High:46.11
Open:45.26
Low:45.25
Close:45.15
52wk High:52.68
52wk Low:40.89
Shares:2.40B
Float Shares:2.16B
Volume Ratio:0.71
T/O Rate:0.09%
Dividend:2.40
Dividend Rate:5.24%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.36
PE(LYR):12.20

Loading ...

Sanofi's New CEO Might be Done with Major Portfolio Pruning

Dow Jones
·
Jul 30

Sanofi Might be Better Off Favoring Deals over Internal Drugs

Dow Jones
·
Jul 30

Sanofi Targets Dual RSV–HMPV Opportunity With Fresh Phase 1/2 Vaccine Study

TIPRANKS
·
Jul 30

Sanofi Pauses Key Bronchiectasis Trial, Raising Questions For SNY Investors

TIPRANKS
·
Jul 30

Movement Alert|Sanofi SA Rises 3.07% in Regular Trading, Pharma Sector Rallies Ahead of Q2 Earnings

Market Focus
·
Jul 28

Sanofi SA Expected to Post Earnings of $1.14 a Share - Earnings Preview

Reuters
·
Jul 28

Sanofi New CEO's Plans Take Spotlight

Dow Jones
·
Jul 28

Top Midday Gainers

MT Newswires Live
·
Jul 25

Sanofi Advances Real-World Asthma Study, Sharpening Its Long-Term Biologics Strategy

TIPRANKS
·
Jul 25

Sanofi Halts Development of Atopic Dermatitis Drug

MT Newswires Live
·
Jul 24

Scribe Therapeutics Prices Upsized IPO at $15 per Share

MT Newswires Live
·
Jul 24

Earning Preview: Sanofi SA this quarter’s revenue is expected to increase by 9.85%, and institutional views are bullish

Earnings Agent
·
Jul 24

Sanofi announces Executive Committee to support next strategic chapter

TIPRANKS
·
Jul 22

European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading

MT Newswires Live
·
Jul 20

Sanofi Sues Pfizer, Moderna over COVID Shot Technology

Reuters
·
Jul 15

Movement Alert|Sanofi Falls 3.23% in Pre-Market Trading, Trading at $43.32

Market Focus
·
Jul 14

Movement Alert|Sanofi Declines 3.23% Overnight, Trading at $42.58

Market Focus
·
Jul 14

Analysts Conflicted on These Healthcare Names: Sanofi (SNY) and Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 11

Sanofi Says US FDA Approves Subcutaneous Sarclisa for Multiple Myeloma

MT Newswires Live
·
Jul 10

Sanofi to Address Competition Concerns Over Communication Campaign, European Commission Says

MT Newswires Live
·
Jul 08